1,910 reports of this reaction
3.6% of all DESVENLAFAXINE SUCCINATE reports
#3 most reported adverse reaction
HEADACHE is the #3 most commonly reported adverse reaction for DESVENLAFAXINE SUCCINATE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 1,910 FDA adverse event reports linking DESVENLAFAXINE SUCCINATE to HEADACHE. This represents approximately 3.6% of all 53,036 adverse event reports for this drug.
Patients taking DESVENLAFAXINE SUCCINATE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among DESVENLAFAXINE SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for DESVENLAFAXINE SUCCINATE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 1,910 FDA reports for DESVENLAFAXINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.6% of all adverse event reports for DESVENLAFAXINE SUCCINATE, making it one of the most commonly reported side effect.
If you experience headache while taking DESVENLAFAXINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.